Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28672997 | 0.78 | ALDH1A1 (0.44) | ALDH1A1CYP3A4 | |
| SCHEMBL27716709 | 0.78 | ALDH1A1 (0.35) | CD44ALDH1A1GAA | |
| SCHEMBL27716615 | 0.73 | TDP1 (0.45) | ALDH1A1GAAMAPTCYP3A4 | |
| SCHEMBL27716582 | 0.69 | TSHR (0.45) | ALDH1A1GAAMAPTCYP3A4 | |
| SCHEMBL1172198 | 0.67 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL2670000 | 0.66 | CYP3A4 (0.52) | CD44ALDH1A1GAAMAPTCYP3A4 | |
| SCHEMBL22922896 | 0.66 | ALDH1A1 (0.52) | CD44ALDH1A1GAAMAPTCYP3A4 | |
| SCHEMBL5528095 | 0.66 | CASP1 (0.44) | CD44ALDH1A1GAAMAPTCYP3A4 | |
| SCHEMBL27443748 | 0.66 | ALDH1A1 (0.35) | ALDH1A1MAPTCYP3A4 | |
| SCHEMBL27576407 | 0.66 | PMM2 (0.41) | ALDH1A1MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101282945-A | Compositions and methods for inhibiting the JAK pathway | RIGEL PHARMACEUTICALS INC (US) | 2008-10-08 | — | — | CN | disclosed |